Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Index of microvascular resistance and outcomes following intra-coronary thrombolysis with percutaneous intervention in STEMI: a meta-analysis of randomized control trials

Abstract

Microvascular obstruction following percutaneous coronary intervention (PCI) is highly prevalent and independently associated with adverse clinical outcomes. Microvascular obstruction is determined by index of the microvascular resistance. We performed a systematic review with meta-analysis of all published randomized clinical trials (RCTs) studying the effect of intra-coronary thrombolysis with PCI as compared to standard treatment among patients with ST-segment elevated myocardial infarction. We included 6 RCTs summing up to 947 patients in the final analysis. Intra-coronary thrombolysis resulted in significantly lower index of microvascular resistance [standardized mean difference: − 13.74, 95% confidence interval (CI): − 16.74 to − 10.73, P value < 0.001, I2 = 0%]. There was no difference noted in the occurrence of major adverse cardiac events with intra-coronary thrombolysis as compared to standard treatment [Odds ratio:  0.71, 95% CI: 0.46–1.08, P value = 0.11,  I2 = 0%]. The absence of heterogeneity deferred us from using dose–response analysis to account for altering dose used across studies. The results of the present meta-analysis highlights the role of intra-coronary thrombolysis in reducing microvascular obstruction. No effect of intra-coronary thrombolysis was noted on the occurrence of major adverse cardiac events.

This is a preview of subscription content, log in to check access.

Fig. 1

Reference

  1. 1.

    Roth GA, Abate D, Abate KH et al (2018) Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2013;2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392:1736–1788. https://doi.org/10.1016/S0140-6736(18)32203-7

  2. 2.

    WK C, A. ZE MJR et al (1998) Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97:765–772. https://doi.org/10.1161/01.CIR.97.8.765

  3. 3.

    Henriques JPS, Zijlstra F, Ottervanger JP et al (2002) Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 23:1112–1117. https://doi.org/10.1053/euhj.2001.3035

  4. 4.

    de Waha S, Patel MR, Granger CB et al (2017) Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials. Eur Heart J 38:3502–3510. https://doi.org/10.1093/eurheartj/ehx414

  5. 5.

    Stone GW, Maehara A, Witzenbichler B et al (2012) Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial Abciximab and Aspiration Thrombectomy. JAMA 307:1817–1826. https://doi.org/10.1001/jama.2012.421

  6. 6.

    McCartney PJ, Eteiba H, Maznyczka AM et al (2019) Effect of low-dose intracoronary alteplase during primary percutaneous coronary intervention on microvascular obstruction in patients with acute myocardial infarction: a randomized clinical trial. JAMA 321:56–68. https://doi.org/10.1001/jama.2018.19802

  7. 7.

    McCartney PJ, Eteiba H, Maznyczka AM et al (2006) Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 367:569–578. https://doi.org/10.1016/S0140-6736(06)68147-6

  8. 8.

    Fu Y, Gu X-S, Hao G-Z et al (2019) Comparison of myocardial microcirculatory perfusion after catheter-administered intracoronary thrombolysis with anisodamine versus standard thrombus aspiration in patients with ST-elevation myocardial infarction. Catheter Cardiovasc Interv 93:839–845. https://doi.org/10.1002/ccd.28112

  9. 9.

    Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700. https://doi.org/10.1136/bmj.b2700

  10. 10.

    Sezer M, Oflaz H, Gören T et al (2007) Intracoronary streptokinase after primary percutaneous coronary intervention. N Engl J Med 356:1823–1834. https://doi.org/10.1056/NEJMoa054374

  11. 11.

    Sezer M, Cimen A, Aslanger E et al (2009) Effect of intracoronary streptokinase administered immediately after primary percutaneous coronary intervention on long-term left ventricular infarct size, volumes, and function. J Am Coll Cardiol 54:1065–1071. https://doi.org/10.1016/j.jacc.2009.04.083

  12. 12.

    Greco C, Pelliccia F, Tanzilli G et al (2013) Usefulness of local delivery of thrombolytics before thrombectomy in patients&amp;nbsp;with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (the delivery of thrombolytics before thrombectomy in patients&amp;nbsp;with ST-segment. Am J Cardiol 112:630–635. https://doi.org/10.1016/j.amjcard.2013.04.036

  13. 13.

    Geng W, Zhang Q, Liu J et al (2017) A randomized study of prourokinase during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction. J Interv Cardiol (no pagina. https://doi.org/10.1111/joic.12461

  14. 14.

    Sezer M, Umman S (2019) Fibrinolytic therapy to reduce microvascular obstruction after myocardial infarction. JAMA 321:2032. https://doi.org/10.1001/jama.2019.2776

Download references

Author information

Correspondence to Ashish Kumar.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

Below is the link to the electronic supplementary material

Supplementary file1 (DOCX 46 kb)

Supplementary file2 (DOCX 15 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kumar, A., Shariff, M. & Doshi, R. Index of microvascular resistance and outcomes following intra-coronary thrombolysis with percutaneous intervention in STEMI: a meta-analysis of randomized control trials. J Thromb Thrombolysis (2020). https://doi.org/10.1007/s11239-020-02063-1

Download citation

Keywords

  • Intra-coronary thrombolysis
  • Microvascular obstruction
  • Index of microvascular resistance